Analyzing differences between restricted mean survival time curves using pseudo-values

by   Federico Ambrogi, et al.

Hazard ratios are ubiquitously used in time to event analysis to quantify treatment effects. Although hazard ratios are invaluable for hypothesis testing, other measures of association, both relative and absolute, may be used to fully elucidate study results. Restricted mean survival time differences between groups have been advocated as useful measures of association. Recent work focused on model-free estimates of the difference in restricted mean survival for all follow-up times instead of focusing on a single time horizon. In this work a model-based alternative is proposed with estimation using pseudo-values. A simple approach is proposed easily implementable with available software. It is also possible to compute a confidence region for the curve. As a by-product, the parameter 'time until treatment equipoise' (TUTE) is also studied. Examples with crossing survival curves will be used to illustrate the different methods together with some simulations.



page 1

page 2

page 3

page 4


Nonparametric Analysis of Delayed Treatment Effects using Single-Crossing Constraints

Clinical trials involving novel immuno-oncology (IO) therapies frequentl...

A framework for meta-analysis through standardized survival curves

Meta-analyses of survival studies aim to reveal the variation of an effe...

Mean survival by ordered fractions of population with censored data

We propose a novel approach for estimating mean survival time in the pre...

Efficient model-based Bioequivalence Testing

The classical approach to analyze pharmacokinetic (PK) data in bioequiva...

Analysis of survival data with non-proportional hazards: A comparison of propensity score weighted methods

One of the most common ways researchers compare survival outcomes across...

Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards

In the process of clinical diagnosis and treatment, the restricted mean ...

Why comparing survival curves between two prognostic subgroups may be misleading

We consider the validation of prognostic diagnostic tests that predict t...
This week in AI

Get the week's most popular data science and artificial intelligence research sent straight to your inbox every Saturday.